Høvik, Norway-based Nattopharma ASA announced its exclusive distribution agreement with Glanbia Nutritionals, whereby NattoPharma’s new ingredient, MenaQ7 PURE will be distributed throughout the United States and Canada by Glanbia Nutritionals.

Hogne Vik, CEO, NattoPharma said MenaQ7 PURE is the newest offering to Glanbia Nutritionals’ arsenal of unique, proprietary, branded, clinically substantiated, and validated ingredients.”The market for vitamin K2 as MK-7 is clearly expanding as the scientific evidence of its ability to promote bone and cardiovascular health continues to accumulate. As vitamin K2 awareness has been rapidly growing, NattoPharma has been fielding an influx of inquiries,” said Vik, adding “Glanbia Nutritionals’ broad and deep customer base will benefit from this vital new offering, which will further enhance NattoPharma’s U.S. presence.”